These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 8327469

  • 21. Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells.
    Shannon EJ, Sandoval F.
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):59-72. PubMed ID: 8683039
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer.
    Li Y, Starr SE, Lisziewicz J, Ho WZ.
    Gene Ther; 2000 Feb; 7(4):321-8. PubMed ID: 10694813
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage.
    Saville MW, Taga K, Foli A, Broder S, Tosato G, Yarchoan R.
    Blood; 1994 Jun 15; 83(12):3591-9. PubMed ID: 7911340
    [Abstract] [Full Text] [Related]

  • 24. Salmonella typhimurium-induced reactivation of latent HIV-1 in promonocytic U1 cells is inhibited by trovafloxacin.
    Gollapudi S, Gupta S, Thadepalli H.
    Int J Mol Med; 2000 Jun 15; 5(6):615-8. PubMed ID: 10812011
    [Abstract] [Full Text] [Related]

  • 25. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection.
    Klausner JD, Makonkawkeyoon S, Akarasewi P, Nakata K, Kasinrerk W, Corral L, Dewar RL, Lane HC, Freedman VH, Kaplan G.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar 01; 11(3):247-57. PubMed ID: 8603261
    [Abstract] [Full Text] [Related]

  • 26. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine.
    Bagasra O, Pomerantz RJ.
    J Infect Dis; 1993 Nov 01; 168(5):1157-64. PubMed ID: 8228349
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1.
    Popik W, Pitha PM.
    J Virol; 1993 Feb 01; 67(2):1094-9. PubMed ID: 8419639
    [Abstract] [Full Text] [Related]

  • 29. Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani.
    Bernier R, Turco SJ, Olivier M, Tremblay M.
    J Virol; 1995 Nov 01; 69(11):7282-5. PubMed ID: 7474154
    [Abstract] [Full Text] [Related]

  • 30. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
    Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS.
    Science; 1989 May 05; 244(4904):575-7. PubMed ID: 2470148
    [Abstract] [Full Text] [Related]

  • 31. Opiates, human peripheral blood mononuclear cells, and HIV.
    Peterson PK, Sharp BM, Gekker G, Jackson B, Balfour HH.
    Adv Exp Med Biol; 1991 May 05; 288():171-8. PubMed ID: 1950731
    [No Abstract] [Full Text] [Related]

  • 32. Generation of endogenous tumour necrosis factor-alpha in MOLT-4 cells during the acute replication phase of human immunodeficiency virus type 1 determines the subsequent latent infection.
    Fujinaga K, Nakaya T, Ikuta K.
    J Gen Virol; 1998 Feb 05; 79 ( Pt 2)():221-9. PubMed ID: 9472606
    [Abstract] [Full Text] [Related]

  • 33. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W, Pitha PM.
    Virology; 1994 Aug 01; 202(2):521-9. PubMed ID: 8030218
    [Abstract] [Full Text] [Related]

  • 34. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.
    Howard OM, Clouse KA, Smith C, Goodwin RG, Farrar WL.
    Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2335-9. PubMed ID: 7681592
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes.
    Sperber K, Kalb TH, Stecher VJ, Banerjee R, Mayer L.
    AIDS Res Hum Retroviruses; 1993 Jan 15; 9(1):91-8. PubMed ID: 8427717
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM, Lima PG, Filho RG, Hygino J, Milczanowski SF, Andrade AF, Lauria C, Brindeiro R, Tanuri A, Bento CA.
    AIDS; 2007 Aug 20; 21(13):1763-70. PubMed ID: 17690575
    [Abstract] [Full Text] [Related]

  • 37. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
    Ho JL, He S, Hu A, Geng J, Basile FG, Almeida MG, Saito AY, Laurence J, Johnson WD.
    J Exp Med; 1995 Apr 01; 181(4):1493-505. PubMed ID: 7699332
    [Abstract] [Full Text] [Related]

  • 38. Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide.
    Jiménez JL, González-Nicolás J, Alvarez S, Fresno M, Muñoz-Fernández MA.
    J Virol; 2001 May 01; 75(10):4655-63. PubMed ID: 11312336
    [Abstract] [Full Text] [Related]

  • 39. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR.
    Mol Med; 1995 Sep 01; 1(6):667-77. PubMed ID: 8529133
    [Abstract] [Full Text] [Related]

  • 40. 9-nitrocamptothecin selectively inhibits human immunodeficiency virus type 1 replication in freshly infected parental but not 9-nitrocamptothecin-resistant U937 monocytoid cells.
    Sadaie MR, Doniger J, Hung CL, Pantazis P.
    AIDS Res Hum Retroviruses; 1999 Feb 10; 15(3):239-45. PubMed ID: 10052754
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.